nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—NOS3—glaucoma	0.579	0.783	CbGaD
Tetrahydrobiopterin—PTGS2—glaucoma	0.16	0.217	CbGaD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP1—glaucoma	0.000586	0.00578	CbGpPWpGaD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—BCL2L1—glaucoma	0.000579	0.00571	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000574	0.00565	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000562	0.00554	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—NARFL—glaucoma	0.000558	0.00549	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—CA5A—glaucoma	0.000558	0.00549	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—NR3C1—glaucoma	0.000553	0.00545	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000551	0.00543	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—NTRK1—glaucoma	0.000551	0.00543	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—NGFR—glaucoma	0.000539	0.00531	CbGpPWpGaD
Tetrahydrobiopterin—Nasopharyngitis—Clonidine—glaucoma	0.000528	0.00331	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Brinzolamide—glaucoma	0.000524	0.00329	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Methazolamide—glaucoma	0.000523	0.00328	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Diclofenamide—glaucoma	0.00052	0.00326	CcSEcCtD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—NTRK1—glaucoma	0.000512	0.00504	CbGpPWpGaD
Tetrahydrobiopterin—Mediastinal disorder—Brimonidine—glaucoma	0.000511	0.0032	CcSEcCtD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—NGF—glaucoma	0.000509	0.00502	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—MMP1—glaucoma	0.000508	0.005	CbGpPWpGaD
Tetrahydrobiopterin—Body temperature increased—Carbachol—glaucoma	0.000508	0.00319	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Carbachol—glaucoma	0.000508	0.00319	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Pilocarpine—glaucoma	0.000508	0.00318	CcSEcCtD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000507	0.00499	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—BDNF—glaucoma	0.000504	0.00497	CbGpPWpGaD
Tetrahydrobiopterin—Oedema peripheral—Pilocarpine—glaucoma	0.000504	0.00316	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Carteolol—glaucoma	0.000493	0.00309	CcSEcCtD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—NCK2—glaucoma	0.000488	0.00481	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Bimatoprost—glaucoma	0.000486	0.00305	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.000486	0.00305	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Travoprost—glaucoma	0.000486	0.00305	CcSEcCtD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—SOD1—glaucoma	0.000484	0.00477	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Angiogenesis—MMP9—glaucoma	0.000482	0.00475	CbGpPWpGaD
Tetrahydrobiopterin—Mediastinal disorder—Brinzolamide—glaucoma	0.00048	0.00301	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Methazolamide—glaucoma	0.000479	0.00301	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Metipranolol—glaucoma	0.000478	0.003	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Clonidine—glaucoma	0.000474	0.00298	CcSEcCtD
Tetrahydrobiopterin—Agitation—Acetazolamide—glaucoma	0.000472	0.00296	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.000471	0.00296	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—glaucoma	0.000469	0.00462	CbGpPWpGaD
Tetrahydrobiopterin—Hypersensitivity—Levobunolol—glaucoma	0.000466	0.00292	CcSEcCtD
Tetrahydrobiopterin—Infection—Apraclonidine—glaucoma	0.000466	0.00292	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Brinzolamide—glaucoma	0.000463	0.00291	CcSEcCtD
Tetrahydrobiopterin—Nasal congestion—Timolol—glaucoma	0.000461	0.00289	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Apraclonidine—glaucoma	0.00046	0.00289	CcSEcCtD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—CA1—glaucoma	0.00046	0.00453	CbGpPWpGaD
Tetrahydrobiopterin—Nasopharyngitis—Betaxolol—glaucoma	0.00046	0.00288	CcSEcCtD
Tetrahydrobiopterin—Rash—Metipranolol—glaucoma	0.000456	0.00286	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Apraclonidine—glaucoma	0.000456	0.00286	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Metipranolol—glaucoma	0.000455	0.00286	CcSEcCtD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—glaucoma	0.000454	0.00447	CbGpPWpGaD
Tetrahydrobiopterin—Headache—Metipranolol—glaucoma	0.000453	0.00284	CcSEcCtD
Tetrahydrobiopterin—Infection—Bimatoprost—glaucoma	0.000452	0.00283	CcSEcCtD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—MMP2—glaucoma	0.000451	0.00444	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—NGF—glaucoma	0.000447	0.00441	CbGpPWpGaD
Tetrahydrobiopterin—Nervous system disorder—Bimatoprost—glaucoma	0.000446	0.0028	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Acetazolamide—glaucoma	0.000445	0.00279	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Carteolol—glaucoma	0.000443	0.00278	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Clonidine—glaucoma	0.000442	0.00277	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Bimatoprost—glaucoma	0.000442	0.00277	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000442	0.00435	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Carbachol—glaucoma	0.00044	0.00276	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Diclofenamide—glaucoma	0.000435	0.00273	CcSEcCtD
Tetrahydrobiopterin—NOS3—Angiogenesis—VEGFA—glaucoma	0.000433	0.00427	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Levobunolol—glaucoma	0.000433	0.00272	CcSEcCtD
Tetrahydrobiopterin—Cough—Brimonidine—glaucoma	0.000431	0.0027	CcSEcCtD
Tetrahydrobiopterin—Nausea—Metipranolol—glaucoma	0.000429	0.00269	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Apraclonidine—glaucoma	0.000427	0.00268	CcSEcCtD
Tetrahydrobiopterin—Agitation—Brinzolamide—glaucoma	0.000426	0.00267	CcSEcCtD
Tetrahydrobiopterin—TH—Monoamine Transport—TNF—glaucoma	0.000425	0.00419	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Carbachol—glaucoma	0.000425	0.00267	CcSEcCtD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—FN1—glaucoma	0.000421	0.00414	CbGpPWpGaD
Tetrahydrobiopterin—Arthralgia—Brimonidine—glaucoma	0.00042	0.00264	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—BDNF—glaucoma	0.00042	0.00413	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Acetazolamide—glaucoma	0.00042	0.00263	CcSEcCtD
Tetrahydrobiopterin—Headache—Carteolol—glaucoma	0.000419	0.00263	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Diclofenamide—glaucoma	0.000419	0.00263	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Levobunolol—glaucoma	0.000418	0.00262	CcSEcCtD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—MMP2—glaucoma	0.000418	0.00412	CbGpPWpGaD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.000417	0.00262	CcSEcCtD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—glaucoma	0.000416	0.0041	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Diclofenamide—glaucoma	0.000415	0.0026	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000415	0.00409	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Methazolamide—glaucoma	0.000415	0.0026	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Betaxolol—glaucoma	0.000413	0.00259	CcSEcCtD
Tetrahydrobiopterin—Headache—Diclofenamide—glaucoma	0.000412	0.00259	CcSEcCtD
Tetrahydrobiopterin—Cough—Dorzolamide—glaucoma	0.000411	0.00258	CcSEcCtD
Tetrahydrobiopterin—Cough—Travoprost—glaucoma	0.000409	0.00257	CcSEcCtD
Tetrahydrobiopterin—Agitation—Pilocarpine—glaucoma	0.000409	0.00257	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Carbachol—glaucoma	0.000409	0.00256	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—CA5A—glaucoma	0.000408	0.00402	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—NARFL—glaucoma	0.000408	0.00402	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Carbachol—glaucoma	0.000405	0.00254	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000405	0.00254	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Carbachol—glaucoma	0.000405	0.00254	CcSEcCtD
Tetrahydrobiopterin—Cough—Brinzolamide—glaucoma	0.000404	0.00254	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000403	0.00397	CbGpPWpGaD
Tetrahydrobiopterin—Headache—Carbachol—glaucoma	0.000403	0.00253	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Dorzolamide—glaucoma	0.000401	0.00252	CcSEcCtD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—FAS—glaucoma	0.000401	0.00395	CbGpPWpGaD
Tetrahydrobiopterin—Dyspepsia—Bimatoprost—glaucoma	0.0004	0.00251	CcSEcCtD
Tetrahydrobiopterin—Infection—Brimonidine—glaucoma	0.0004	0.00251	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Travoprost—glaucoma	0.000399	0.00251	CcSEcCtD
Tetrahydrobiopterin—Nausea—Carteolol—glaucoma	0.000398	0.0025	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000397	0.00249	CcSEcCtD
Tetrahydrobiopterin—Headache—Levobunolol—glaucoma	0.000396	0.00249	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Betaxolol—glaucoma	0.000396	0.00249	CcSEcCtD
Tetrahydrobiopterin—Infestation—Betaxolol—glaucoma	0.000396	0.00249	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Brimonidine—glaucoma	0.000395	0.00248	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Brinzolamide—glaucoma	0.000394	0.00247	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000393	0.00246	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000392	0.00246	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Brimonidine—glaucoma	0.000391	0.00245	CcSEcCtD
Tetrahydrobiopterin—Nausea—Diclofenamide—glaucoma	0.000391	0.00245	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Betaxolol—glaucoma	0.000391	0.00245	CcSEcCtD
Tetrahydrobiopterin—Cough—Pilocarpine—glaucoma	0.000389	0.00244	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Betaxolol—glaucoma	0.000388	0.00244	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Latanoprost—glaucoma	0.000388	0.00243	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Methazolamide—glaucoma	0.000385	0.00242	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Dorzolamide—glaucoma	0.000385	0.00241	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Apraclonidine—glaucoma	0.000384	0.00241	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Timolol—glaucoma	0.000384	0.00241	CcSEcCtD
Tetrahydrobiopterin—Rash—Methazolamide—glaucoma	0.000382	0.0024	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Methazolamide—glaucoma	0.000382	0.0024	CcSEcCtD
Tetrahydrobiopterin—Nausea—Carbachol—glaucoma	0.000382	0.00239	CcSEcCtD
Tetrahydrobiopterin—Infection—Travoprost—glaucoma	0.00038	0.00239	CcSEcCtD
Tetrahydrobiopterin—Headache—Methazolamide—glaucoma	0.00038	0.00238	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Pilocarpine—glaucoma	0.000379	0.00238	CcSEcCtD
Tetrahydrobiopterin—Nausea—Levobunolol—glaucoma	0.000376	0.00236	CcSEcCtD
Tetrahydrobiopterin—Infection—Brinzolamide—glaucoma	0.000376	0.00236	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Travoprost—glaucoma	0.000376	0.00236	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Timolol—glaucoma	0.000376	0.00236	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Overview of nanoparticle effects—FN1—glaucoma	0.000373	0.00367	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—NGF—glaucoma	0.000372	0.00367	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—VEGFR1 specific signals—VEGFA—glaucoma	0.000372	0.00367	CbGpPWpGaD
Tetrahydrobiopterin—Skin disorder—Travoprost—glaucoma	0.000372	0.00233	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Apraclonidine—glaucoma	0.000371	0.00233	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Brinzolamide—glaucoma	0.000371	0.00233	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000371	0.00365	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Latanoprost—glaucoma	0.00037	0.00232	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Latanoprost—glaucoma	0.00037	0.00232	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Acetazolamide—glaucoma	0.000369	0.00232	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—LRP12—glaucoma	0.000369	0.00363	CbGpPWpGaD
Tetrahydrobiopterin—Mediastinal disorder—Clonidine—glaucoma	0.000368	0.00231	CcSEcCtD
Tetrahydrobiopterin—Headache—Latanoprost—glaucoma	0.000368	0.00231	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Brinzolamide—glaucoma	0.000367	0.0023	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000367	0.0023	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000362	0.00227	CcSEcCtD
Tetrahydrobiopterin—Infection—Pilocarpine—glaucoma	0.000361	0.00226	CcSEcCtD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—CDKN2A—glaucoma	0.00036	0.00355	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Methazolamide—glaucoma	0.00036	0.00226	CcSEcCtD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—MMP2—glaucoma	0.000357	0.00351	CbGpPWpGaD
Tetrahydrobiopterin—Dyspepsia—Brimonidine—glaucoma	0.000354	0.00222	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Betaxolol—glaucoma	0.000353	0.00221	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.00035	0.0022	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Travoprost—glaucoma	0.000349	0.00219	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Brimonidine—glaucoma	0.000348	0.00218	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Apraclonidine—glaucoma	0.000346	0.00217	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—CAV1—glaucoma	0.000345	0.0034	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000344	0.00216	CcSEcCtD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—glaucoma	0.000341	0.00336	CbGpPWpGaD
Tetrahydrobiopterin—Dyspepsia—Dorzolamide—glaucoma	0.000339	0.00212	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000337	0.00332	CbGpPWpGaD
Tetrahydrobiopterin—Upper respiratory tract infection—Timolol—glaucoma	0.000337	0.00212	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Travoprost—glaucoma	0.000337	0.00211	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Brinzolamide—glaucoma	0.000333	0.00209	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Acetazolamide—glaucoma	0.000332	0.00208	CcSEcCtD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—BCL2L1—glaucoma	0.000332	0.00327	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000331	0.00208	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Travoprost—glaucoma	0.000331	0.00207	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—BDNF—glaucoma	0.00033	0.00325	CbGpPWpGaD
Tetrahydrobiopterin—Agitation—Clonidine—glaucoma	0.000327	0.00205	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000326	0.00205	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Apraclonidine—glaucoma	0.000321	0.00201	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Betaxolol—glaucoma	0.000321	0.00201	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—CA5A—glaucoma	0.00032	0.00315	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—NARFL—glaucoma	0.00032	0.00315	CbGpPWpGaD
Tetrahydrobiopterin—Dyspepsia—Pilocarpine—glaucoma	0.00032	0.00201	CcSEcCtD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—CDKN1B—glaucoma	0.000319	0.00314	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000316	0.00312	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Dorzolamide—glaucoma	0.000314	0.00197	CcSEcCtD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—MMP9—glaucoma	0.000314	0.0031	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000314	0.00197	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Travoprost—glaucoma	0.000313	0.00196	CcSEcCtD
Tetrahydrobiopterin—Cough—Clonidine—glaucoma	0.00031	0.00195	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Apraclonidine—glaucoma	0.00031	0.00195	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Betaxolol—glaucoma	0.00031	0.00194	CcSEcCtD
Tetrahydrobiopterin—TH—Circadian rythm related genes—NGFR—glaucoma	0.000309	0.00305	CbGpPWpGaD
Tetrahydrobiopterin—Abdominal pain—Dorzolamide—glaucoma	0.000304	0.00191	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Dorzolamide—glaucoma	0.000304	0.00191	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Clonidine—glaucoma	0.000303	0.0019	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Travoprost—glaucoma	0.000303	0.0019	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Bimatoprost—glaucoma	0.000301	0.00189	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000301	0.00189	CcSEcCtD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—BAD—glaucoma	0.0003	0.00296	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Apraclonidine—glaucoma	0.000298	0.00187	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Pilocarpine—glaucoma	0.000297	0.00186	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Brimonidine—glaucoma	0.000297	0.00186	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000296	0.00292	CbGpPWpGaD
Tetrahydrobiopterin—Dermatitis—Apraclonidine—glaucoma	0.000295	0.00185	CcSEcCtD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—MMP9—glaucoma	0.000295	0.00291	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—NTRK1—glaucoma	0.000294	0.0029	CbGpPWpGaD
Tetrahydrobiopterin—Headache—Apraclonidine—glaucoma	0.000294	0.00184	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—NGF—glaucoma	0.000293	0.00288	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000291	0.00287	CbGpPWpGaD
Tetrahydrobiopterin—Infection—Clonidine—glaucoma	0.000288	0.00181	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Pilocarpine—glaucoma	0.000287	0.0018	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Pilocarpine—glaucoma	0.000287	0.0018	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Acetazolamide—glaucoma	0.000287	0.0018	CcSEcCtD
Tetrahydrobiopterin—Rash—Bimatoprost—glaucoma	0.000287	0.0018	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Bimatoprost—glaucoma	0.000286	0.0018	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Timolol—glaucoma	0.000286	0.0018	CcSEcCtD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—MMP2—glaucoma	0.000286	0.00281	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—TXN—glaucoma	0.000286	0.00281	CbGpPWpGaD
Tetrahydrobiopterin—Headache—Bimatoprost—glaucoma	0.000285	0.00179	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Clonidine—glaucoma	0.000285	0.00179	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Dorzolamide—glaucoma	0.000283	0.00178	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Travoprost—glaucoma	0.000282	0.00177	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Clonidine—glaucoma	0.000282	0.00177	CcSEcCtD
Tetrahydrobiopterin—Nausea—Apraclonidine—glaucoma	0.000279	0.00175	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Brinzolamide—glaucoma	0.000279	0.00175	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Acetazolamide—glaucoma	0.000277	0.00174	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000277	0.00273	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—CA1—glaucoma	0.000272	0.00268	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Betaxolol—glaucoma	0.00027	0.00169	CcSEcCtD
Tetrahydrobiopterin—Nausea—Bimatoprost—glaucoma	0.00027	0.00169	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Pilocarpine—glaucoma	0.000268	0.00168	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Acetazolamide—glaucoma	0.000267	0.00167	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Brimonidine—glaucoma	0.000266	0.00167	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Clonidine—glaucoma	0.000264	0.00166	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—CTSA—glaucoma	0.000264	0.0026	CbGpPWpGaD
Tetrahydrobiopterin—Arthralgia—Betaxolol—glaucoma	0.000264	0.00165	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Dorzolamide—glaucoma	0.000263	0.00165	CcSEcCtD
Tetrahydrobiopterin—Headache—Acetazolamide—glaucoma	0.000263	0.00165	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Travoprost—glaucoma	0.000262	0.00164	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Timolol—glaucoma	0.000262	0.00164	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000262	0.00164	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Brinzolamide—glaucoma	0.000259	0.00162	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Dorzolamide—glaucoma	0.000254	0.0016	CcSEcCtD
Tetrahydrobiopterin—Rash—Brimonidine—glaucoma	0.000254	0.00159	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Brimonidine—glaucoma	0.000254	0.00159	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—C1QB—glaucoma	0.000253	0.0025	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Travoprost—glaucoma	0.000253	0.00159	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Timolol—glaucoma	0.000253	0.00159	CcSEcCtD
Tetrahydrobiopterin—Headache—Brimonidine—glaucoma	0.000252	0.00158	CcSEcCtD
Tetrahydrobiopterin—Infection—Betaxolol—glaucoma	0.000251	0.00157	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Clonidine—glaucoma	0.000251	0.00157	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Brinzolamide—glaucoma	0.00025	0.00157	CcSEcCtD
Tetrahydrobiopterin—Nausea—Acetazolamide—glaucoma	0.000249	0.00156	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—CA2—glaucoma	0.000249	0.00245	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Pilocarpine—glaucoma	0.000249	0.00156	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Betaxolol—glaucoma	0.000248	0.00155	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Betaxolol—glaucoma	0.000245	0.00154	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	0.000245	0.00241	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Dorzolamide—glaucoma	0.000245	0.00153	CcSEcCtD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000243	0.0024	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Dorzolamide—glaucoma	0.000242	0.00152	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Dorzolamide—glaucoma	0.000242	0.00152	CcSEcCtD
Tetrahydrobiopterin—Rash—Travoprost—glaucoma	0.000241	0.00151	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Travoprost—glaucoma	0.000241	0.00151	CcSEcCtD
Tetrahydrobiopterin—Headache—Dorzolamide—glaucoma	0.000241	0.00151	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—CAV1—glaucoma	0.00024	0.00237	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Brinzolamide—glaucoma	0.00024	0.00151	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Pilocarpine—glaucoma	0.00024	0.00151	CcSEcCtD
Tetrahydrobiopterin—Headache—Travoprost—glaucoma	0.00024	0.0015	CcSEcCtD
Tetrahydrobiopterin—Nausea—Brimonidine—glaucoma	0.000239	0.0015	CcSEcCtD
Tetrahydrobiopterin—Rash—Brinzolamide—glaucoma	0.000238	0.0015	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Brinzolamide—glaucoma	0.000238	0.00149	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—FGFR1OP—glaucoma	0.000238	0.00234	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—HEYL—glaucoma	0.000238	0.00234	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Clonidine—glaucoma	0.000237	0.00149	CcSEcCtD
Tetrahydrobiopterin—Headache—Brinzolamide—glaucoma	0.000237	0.00149	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Pilocarpine—glaucoma	0.000231	0.00145	CcSEcCtD
Tetrahydrobiopterin—TH—Circadian rythm related genes—FAS—glaucoma	0.00023	0.00227	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Betaxolol—glaucoma	0.00023	0.00144	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Clonidine—glaucoma	0.000229	0.00144	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Clonidine—glaucoma	0.000229	0.00144	CcSEcCtD
Tetrahydrobiopterin—Rash—Pilocarpine—glaucoma	0.000229	0.00144	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Pilocarpine—glaucoma	0.000229	0.00144	CcSEcCtD
Tetrahydrobiopterin—Nausea—Dorzolamide—glaucoma	0.000228	0.00143	CcSEcCtD
Tetrahydrobiopterin—Headache—Pilocarpine—glaucoma	0.000228	0.00143	CcSEcCtD
Tetrahydrobiopterin—Nausea—Travoprost—glaucoma	0.000227	0.00143	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—CAV1—glaucoma	0.000227	0.00224	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Brinzolamide—glaucoma	0.000225	0.00141	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Betaxolol—glaucoma	0.000222	0.0014	CcSEcCtD
Tetrahydrobiopterin—NOS3—Metabolism—CA5A—glaucoma	0.000222	0.00219	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—NARFL—glaucoma	0.000222	0.00219	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Timolol—glaucoma	0.000221	0.00138	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Betaxolol—glaucoma	0.000218	0.00137	CcSEcCtD
Tetrahydrobiopterin—Nausea—Pilocarpine—glaucoma	0.000216	0.00135	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Timolol—glaucoma	0.000215	0.00135	CcSEcCtD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—MMP9—glaucoma	0.000215	0.00211	CbGpPWpGaD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000214	0.00134	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Clonidine—glaucoma	0.000214	0.00134	CcSEcCtD
Tetrahydrobiopterin—NOS3—SHP2 signaling—VEGFA—glaucoma	0.000214	0.00211	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—S1P1 pathway—VEGFA—glaucoma	0.000213	0.0021	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—TNF—glaucoma	0.000209	0.00205	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Timolol—glaucoma	0.000206	0.00129	CcSEcCtD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—TNF—glaucoma	0.000206	0.00203	CbGpPWpGaD
Tetrahydrobiopterin—Infection—Timolol—glaucoma	0.000205	0.00129	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Timolol—glaucoma	0.000202	0.00127	CcSEcCtD
Tetrahydrobiopterin—NOS3—Disease—LRP12—glaucoma	0.000201	0.00198	CbGpPWpGaD
Tetrahydrobiopterin—Skin disorder—Timolol—glaucoma	0.0002	0.00126	CcSEcCtD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—TP53—glaucoma	0.0002	0.00198	CbGpPWpGaD
Tetrahydrobiopterin—Body temperature increased—Betaxolol—glaucoma	0.0002	0.00125	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—CA1—glaucoma	0.000199	0.00196	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Clonidine—glaucoma	0.000199	0.00125	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—CTSA—glaucoma	0.000193	0.0019	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Clonidine—glaucoma	0.000192	0.0012	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—glaucoma	0.000188	0.00185	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Timolol—glaucoma	0.000188	0.00118	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Betaxolol—glaucoma	0.000186	0.00117	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Clonidine—glaucoma	0.000185	0.00116	CcSEcCtD
Tetrahydrobiopterin—Rash—Clonidine—glaucoma	0.000183	0.00115	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Overview of nanoparticle effects—TNF—glaucoma	0.000183	0.0018	CbGpPWpGaD
Tetrahydrobiopterin—Dermatitis—Clonidine—glaucoma	0.000183	0.00115	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—CA2—glaucoma	0.000182	0.00179	CbGpPWpGaD
Tetrahydrobiopterin—Headache—Clonidine—glaucoma	0.000182	0.00114	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Timolol—glaucoma	0.000182	0.00114	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Timolol—glaucoma	0.000178	0.00112	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000178	0.00175	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—ABCA1—glaucoma	0.000176	0.00174	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—TXN—glaucoma	0.000175	0.00173	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Betaxolol—glaucoma	0.000173	0.00108	CcSEcCtD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—CAV1—glaucoma	0.000173	0.0017	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Clonidine—glaucoma	0.000172	0.00108	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Timolol—glaucoma	0.000169	0.00106	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Betaxolol—glaucoma	0.000167	0.00105	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Timolol—glaucoma	0.000163	0.00102	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Timolol—glaucoma	0.000163	0.00102	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Betaxolol—glaucoma	0.000161	0.00101	CcSEcCtD
Tetrahydrobiopterin—Rash—Betaxolol—glaucoma	0.000159	0.000999	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Betaxolol—glaucoma	0.000159	0.000998	CcSEcCtD
Tetrahydrobiopterin—Headache—Betaxolol—glaucoma	0.000158	0.000993	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—SOD1—glaucoma	0.000157	0.00155	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—CA1—glaucoma	0.000156	0.00154	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—TNF—glaucoma	0.000152	0.0015	CbGpPWpGaD
Tetrahydrobiopterin—Hypersensitivity—Timolol—glaucoma	0.000152	0.000954	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—CTSA—glaucoma	0.000151	0.00149	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—TP53—glaucoma	0.00015	0.00148	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Betaxolol—glaucoma	0.00015	0.000941	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—HDAC9—glaucoma	0.000148	0.00146	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—GSTM1—glaucoma	0.000146	0.00144	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—CA2—glaucoma	0.000143	0.00141	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Timolol—glaucoma	0.000141	0.000886	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling Pathways—LRP12—glaucoma	0.000141	0.00139	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.00014	0.00138	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Timolol—glaucoma	0.000136	0.000856	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—GSTT1—glaucoma	0.000136	0.00134	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—NGFR—glaucoma	0.000134	0.00132	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Timolol—glaucoma	0.000131	0.000823	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—VEGFA—glaucoma	0.000131	0.00129	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Timolol—glaucoma	0.00013	0.000816	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Timolol—glaucoma	0.00013	0.000816	CcSEcCtD
Tetrahydrobiopterin—NOS3—Disease—FGFR1OP—glaucoma	0.000129	0.00128	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HEYL—glaucoma	0.000129	0.00128	CbGpPWpGaD
Tetrahydrobiopterin—Headache—Timolol—glaucoma	0.000129	0.000811	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—TXN—glaucoma	0.000128	0.00126	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000127	0.00125	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.000126	0.00124	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TGFB2—glaucoma	0.000125	0.00123	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—MTHFR—glaucoma	0.000125	0.00123	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—VEGFA—glaucoma	0.000124	0.00122	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Timolol—glaucoma	0.000123	0.000769	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—TNF—glaucoma	0.00012	0.00118	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—BDNF—glaucoma	0.000117	0.00115	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000116	0.00115	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—IL1A—glaucoma	0.000112	0.00111	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—ABCA1—glaucoma	0.000108	0.00107	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—CYP1B1—glaucoma	0.000108	0.00107	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CA1—glaucoma	0.000108	0.00107	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000105	0.00104	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CTSA—glaucoma	0.000105	0.00103	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—TXN—glaucoma	0.000101	0.000993	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—GSTT1—glaucoma	9.95e-05	0.00098	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CA2—glaucoma	9.91e-05	0.000977	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	9.89e-05	0.000975	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—OPN4—glaucoma	9.75e-05	0.000961	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	9.64e-05	0.00095	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—SOD1—glaucoma	9.49e-05	0.000935	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CA5A—glaucoma	9.08e-05	0.000894	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NARFL—glaucoma	9.08e-05	0.000894	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HEYL—glaucoma	9.06e-05	0.000893	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—TNF—glaucoma	9.02e-05	0.000889	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—CDKN2A—glaucoma	8.82e-05	0.000869	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PTGFR—glaucoma	8.78e-05	0.000865	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	8.68e-05	0.000855	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—GSTM1—glaucoma	8.67e-05	0.000854	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—TP53—glaucoma	8.62e-05	0.000849	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	8.44e-05	0.000831	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—LRP12—glaucoma	8.21e-05	0.000809	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HDAC9—glaucoma	8.08e-05	0.000796	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	8e-05	0.000788	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CDKN2B—glaucoma	7.98e-05	0.000786	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	7.95e-05	0.000783	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—CYP1B1—glaucoma	7.93e-05	0.000781	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—ABCA1—glaucoma	7.93e-05	0.000781	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—CDKN1B—glaucoma	7.82e-05	0.00077	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—GSTT1—glaucoma	7.81e-05	0.00077	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—MTHFR—glaucoma	7.66e-05	0.000755	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—MMP1—glaucoma	7.23e-05	0.000713	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—APOE—glaucoma	7.13e-05	0.000702	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—CAV1—glaucoma	7.06e-05	0.000696	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—TXN—glaucoma	6.98e-05	0.000688	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—CAV1—glaucoma	6.94e-05	0.000683	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RPTOR—glaucoma	6.87e-05	0.000677	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	6.8e-05	0.00067	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—MTHFR—glaucoma	6.69e-05	0.000659	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NCK2—glaucoma	6.65e-05	0.000655	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—FN1—glaucoma	6.6e-05	0.00065	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—GSTM1—glaucoma	6.34e-05	0.000624	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—ABCA1—glaucoma	6.23e-05	0.000613	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—CYP1B1—glaucoma	6.23e-05	0.000613	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—APOE—glaucoma	6.22e-05	0.000613	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CAV1—glaucoma	6.17e-05	0.000608	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CDKN1B—glaucoma	5.95e-05	0.000587	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	5.82e-05	0.000573	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—BAD—glaucoma	5.8e-05	0.000571	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HDAC9—glaucoma	5.66e-05	0.000557	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—MTHFR—glaucoma	5.6e-05	0.000552	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—MMP9—glaucoma	5.52e-05	0.000543	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—GSTT1—glaucoma	5.42e-05	0.000534	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	5.37e-05	0.000529	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—NOS3—glaucoma	5.34e-05	0.000526	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HEYL—glaucoma	5.29e-05	0.000522	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FGFR1OP—glaucoma	5.29e-05	0.000522	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—APOE—glaucoma	5.21e-05	0.000514	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—CAV1—glaucoma	5.17e-05	0.000509	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—GSTM1—glaucoma	4.98e-05	0.00049	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PTGS2—glaucoma	4.89e-05	0.000481	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—NOS3—glaucoma	4.66e-05	0.000459	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CA1—glaucoma	4.43e-05	0.000437	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SMO—glaucoma	4.43e-05	0.000436	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—MTHFR—glaucoma	4.4e-05	0.000433	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CDKN2B—glaucoma	4.34e-05	0.000428	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CYP1B1—glaucoma	4.32e-05	0.000425	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ABCA1—glaucoma	4.32e-05	0.000425	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CTSA—glaucoma	4.29e-05	0.000423	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PTGS2—glaucoma	4.27e-05	0.00042	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TNF—glaucoma	4.24e-05	0.000418	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—APOE—glaucoma	4.09e-05	0.000403	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—CAV1—glaucoma	4.06e-05	0.0004	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CA2—glaucoma	4.05e-05	0.000399	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	4.05e-05	0.000399	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NTRK2—glaucoma	4.05e-05	0.000399	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CDKN1B—glaucoma	4.04e-05	0.000398	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.96e-05	0.00039	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.96e-05	0.00039	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—NOS3—glaucoma	3.91e-05	0.000385	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—VEGFA—glaucoma	3.78e-05	0.000372	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TP53—glaucoma	3.74e-05	0.000369	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MTHFR—glaucoma	3.64e-05	0.000359	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PTGS2—glaucoma	3.57e-05	0.000352	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NGFR—glaucoma	3.47e-05	0.000342	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—GSTM1—glaucoma	3.45e-05	0.00034	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—APOE—glaucoma	3.39e-05	0.000334	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.37e-05	0.000332	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CAV1—glaucoma	3.36e-05	0.000331	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HDAC9—glaucoma	3.3e-05	0.000325	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NTRK1—glaucoma	3.3e-05	0.000325	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—BAD—glaucoma	3.16e-05	0.000311	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—NOS3—glaucoma	3.07e-05	0.000302	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—MTHFR—glaucoma	3.05e-05	0.0003	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CDKN2B—glaucoma	3.04e-05	0.0003	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EDN1—glaucoma	2.92e-05	0.000288	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.89e-05	0.000284	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—TXN—glaucoma	2.86e-05	0.000281	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TP53—glaucoma	2.86e-05	0.000281	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—APOE—glaucoma	2.84e-05	0.00028	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CAV1—glaucoma	2.81e-05	0.000277	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTGS2—glaucoma	2.81e-05	0.000276	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NGF—glaucoma	2.68e-05	0.000264	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.61e-05	0.000257	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.58e-05	0.000254	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—C3—glaucoma	2.55e-05	0.000251	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.55e-05	0.000251	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—APOE—glaucoma	2.37e-05	0.000234	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CAV1—glaucoma	2.35e-05	0.000232	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTGS2—glaucoma	2.32e-05	0.000229	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FN1—glaucoma	2.24e-05	0.000221	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTT1—glaucoma	2.21e-05	0.000218	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—BAD—glaucoma	2.21e-05	0.000218	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CDKN1B—glaucoma	2.2e-05	0.000217	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTGS2—glaucoma	1.94e-05	0.000192	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CDKN2B—glaucoma	1.78e-05	0.000175	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ABCA1—glaucoma	1.76e-05	0.000174	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP1B1—glaucoma	1.76e-05	0.000174	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CDKN1B—glaucoma	1.54e-05	0.000152	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MTHFR—glaucoma	1.49e-05	0.000147	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MMP9—glaucoma	1.43e-05	0.000141	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTM1—glaucoma	1.41e-05	0.000139	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—APOE—glaucoma	1.39e-05	0.000137	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CAV1—glaucoma	1.37e-05	0.000135	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—BAD—glaucoma	1.29e-05	0.000127	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—VEGFA—glaucoma	1.28e-05	0.000126	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—MTHFR—glaucoma	1.25e-05	0.000123	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—APOE—glaucoma	1.16e-05	0.000114	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CAV1—glaucoma	1.15e-05	0.000113	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NOS3—glaucoma	1.04e-05	0.000102	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TP53—glaucoma	9.68e-06	9.54e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CDKN1B—glaucoma	9e-06	8.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NOS3—glaucoma	8.7e-06	8.57e-05	CbGpPWpGaD
